| Originator: | DHSC & NHS England and Improvement: Supply disruption alert
|
||
| Issue date: | Originally issued on 26-Feb-2021 10:06:20. This version was issued on 26-Feb-2021 10:06:20
|
||
| This alert has been issued to: | |||
|
|||
|
|||
| Action category: | Action
|
||
| Title: | Discontinuation of Morphine sulphate (MST CONTINUS) 20mg, 30mg, 60mg, 100mg and 200mg prolonged release granules for oral suspension
|
||
| Broadcast content: |
All strengths of MST Continus® prolonged release granules for oral suspension are being permanently discontinued during 2021 due to difficulty sourcing a key excipient.
Alternative morphine presentations, both prolonged release and immediate release, remain available and will be able to support increased demand.
This alert contains further information and action for providers.
Please note that no response is required via the CAS website to this alert.
|
||
|
Additional information: |
NHS England and NHS Improvement Regional Offices: Please cascade this alert to Community Pharmacy.
GP Practices please pass on to non-medical prescribers. |
||
| Alert reference: | SDA/2021/004
|
||
| Attachments: |
To view this alert in full please click HERE
